| 35.21 -0.11 (-0.31%) | 03-12 10:50 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 41.51 | 1-year : | 41.76 |
| Resists | First : | 35.54 | Second : | 35.75 |
| Pivot price | 35.53 |
|||
| Supports | First : | 35.18 | Second : | 29.27 |
| MAs | MA(5) : | 35.4 |
MA(20) : | 35.52 |
| MA(100) : | 35.26  |
MA(250) : | 34.21 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 30.5 |
D(3) : | 35.1 |
| RSI | RSI(14): 43.3 | |||
| 52-week | High : | 35.93 | Low : | 31.31 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ XHYH ] has closed above bottom band by 10.0%. Bollinger Bands are 27.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 35.5 - 35.68 | 35.68 - 35.82 |
| Low: | 34.77 - 35.01 | 35.01 - 35.21 |
| Close: | 34.98 - 35.35 | 35.35 - 35.64 |
Under normal circumstances, the fund will invest at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in high-yield, below-investment grade bonds denominated in U.S. dollars of issuers in the healthcare sector, either directly or indirectly (e.g., through derivatives). It is non-diversified.
Sun, 01 Mar 2026
How (XHYH) Movements Inform Risk Allocation Models - Stock Traders Daily
Tue, 24 Feb 2026
Prima BioMed (NASDAQ:IMMP) Now Covered by Analysts at Citizens Jmp - Defense World
Wed, 18 Feb 2026
Trading Systems Reacting to (XHYH) Volatility - Stock Traders Daily
Fri, 17 Jan 2025
Best Performing Fixed Income ETFs of 2024: Total Returns, Income Potential & Volatility - YCharts
Fri, 16 Aug 2024
High Yield Bond ETFs Have New Asset Leader - ETF Trends
Thu, 17 Feb 2022
BondBloxx Debuts With 7 Junk Bond ETFs - ETF.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|